Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

James Bylund Biography and Net Worth

SVP of Repligen

James R. Bylund is Repligen’s Chief Operating Officer, effective January 1, 2022. He joined the Company in March of 2020 as Senior Vice President, Global Operations and IT, overseeing all operations and IT functions on a global basis. Prior to joining Repligen, Mr. Bylund spent ten years at Thermo Fisher Scientific in a number of roles including Vice President and General Manager of the Single Use Technologies Business Unit and Vice President of Global Operations for the Bioproduction Division. Prior to joining Thermo Fisher, Mr. Bylund also worked for Fiserv (9 years) and Eli Lilly and Company (7 years) in a variety of leadership roles. He has significant experience in managing multiple operating sites across the globe and scaling operations to meet rapidly growing demand. Mr. Bylund is a passionate proponent of continuous improvement and has consistently demonstrated the ability to assemble and grow highly effective teams. He holds a B.S in Accounting from Utah State University and an M.B.A. from Indiana University.

What is James Bylund's net worth?: The estimated net worth of James Bylund is at least $1.96 million as of February 23rd, 2024. Mr. Bylund owns 14,135 shares of Repligen stock worth more than $1,963,352 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Bylund may own. Additionally, Mr. Bylund receives an annual salary of $472,180.00 as SVP at Repligen. Learn More about James Bylund's net worth.
How old is James Bylund?: Mr. Bylund is currently 60 years old. There are 3 older executives and no younger executives at Repligen. The oldest executive at Repligen is Mr. Ralf Kuriyel, Senior Vice President of Research & Development, who is 66 years old. Learn More on James Bylund's age.
What is James Bylund's salary?: As the SVP of Repligen Co., Mr. Bylund earns $472,180.00 per year. There are 2 executives that earn more than Mr. Bylund. The highest earning executive at Repligen is Mr. Olivier Loeillot, President, CEO & Director, who commands a salary of $1,490,000.00 per year. Learn More on James Bylund's salary.
How do I contact James Bylund?: The corporate mailing address for Mr. Bylund and other Repligen executives is 41 SEYON STREET BUILDING 1 SUITE 100, WALTHAM MA, 02453. Repligen can also be reached via phone at (781) 250-0111 and via email at [email protected]. Learn More on James Bylund's contact information.
Has James Bylund been buying or selling shares of Repligen?: James Bylund has not been actively trading shares of Repligen during the last ninety days. Most recently, James Bylund sold 4,373 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $198.08, for a transaction totalling $866,203.84. Following the completion of the sale, the chief operating officer now directly owns 14,135 shares of the company's stock, valued at $2,799,860.80. Learn More on James Bylund's trading history.
Who are Repligen's active insiders?: Repligen's insider roster includes Nicolas Barthelemy (Director), James Bylund (SVP), Karen Dawes (Director), Carrie Eglinton Manner (Director), Christine Gebski (Insider), Anthony Hunt (Executive Chair), Ralf Kuriyel (VP), Martin Madaus (Director), Thomas Ryan, Jr. (Director), and Jon Snodgres (CFO). Learn More on Repligen's active insiders.
Are insiders buying or selling shares of Repligen?: In the last year, Repligen insiders bought shares 2 times. They purchased a total of 3,615 shares worth more than $449,938.10. In the last year, insiders at the biotechnology company sold shares 7 times. They sold a total of 72,325 shares worth more than $12,382,469.27. The most recent insider tranaction occured on September, 10th when Director Anthony Hunt sold 22,191 shares worth more than $3,225,905.67. Insiders at Repligen own 1.2% of the company. Learn More about insider trades at Repligen.
Information on this page was last updated on 9/10/2024.

James Bylund Insider Trading History at Repligen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2024	Sell	4,373	$198.08	$866,203.84	14,135
8/3/2022	Sell	2,000	$240.40	$480,800.00	9,733
4/6/2021	Sell	360	$204.25	$73,530.00	6,324

James Bylund Buying and Selling Activity at Repligen

Repligen Company Overview

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $138.90

$138.90

50 Day Range

MA: $140.21

$123.41

$150.47

2 Week Range

Now: $138.90

$113.50

$211.13

Volume

960 shs

Average Volume

667,021 shs

Market Capitalization

$7.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide

James Bylund Biography and Net Worth

What is James Bylund's net worth?

How old is James Bylund?

What is James Bylund's salary?

How do I contact James Bylund?

Has James Bylund been buying or selling shares of Repligen?

Who are Repligen's active insiders?

Are insiders buying or selling shares of Repligen?